| Circular RNAs: biogenesis, function and role in human diseases J Greene, AM Baird, L Brady, M Lim, SG Gray, R McDermott, SP Finn Frontiers in molecular biosciences 4, 38, 2017 | 503 | 2017 |
| Inter-and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling L Brady, M Kriner, I Coleman, C Morrissey, M Roudier, LD True, R Gulati, ... Nature communications 12 (1), 1426, 2021 | 175 | 2021 |
| Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide J Greene, AM Baird, O Casey, L Brady, G Blackshields, M Lim, O o’Brien, ... Scientific Reports 9 (1), 10739, 2019 | 76 | 2019 |
| N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance A Chion, JM O’Sullivan, C Drakeford, G Bergsson, N Dalton, S Aguila, ... Blood, The Journal of the American Society of Hematology 128 (15), 1959-1968, 2016 | 45 | 2016 |
| N‐linked glycan truncation causes enhanced clearance of plasma‐derived von Willebrand factor JM O'sullivan, S Aguila, E McRae, SE Ward, O Rawley, PG Fallon, ... Journal of Thrombosis and Haemostasis 14 (12), 2446-2457, 2016 | 42 | 2016 |
| Exercise and prostate cancer: evidence and proposed mechanisms for disease modification BD Hayes, L Brady, M Pollak, SP Finn Cancer Epidemiology, Biomarkers & Prevention 25 (9), 1281-1288, 2016 | 34 | 2016 |
| Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth MD Nyquist, LS Ang, A Corella, IM Coleman, MP Meers, AJ Christiani, ... The Journal of clinical investigation 131 (10), 2021 | 31 | 2021 |
| Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post‐surgery KJ Breen, A O'Neill, L Murphy, Y Fan, S Boyce, N Fitzgerald, E Dorris, ... The Prostate 77 (12), 1288-1300, 2017 | 17 | 2017 |
| Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial L Brady, B Hayes, G Sheill, AM Baird, E Guinan, B Stanfill, T Vlajnic, ... PLoS One 15 (12), e0243928, 2020 | 16 | 2020 |
| Circulating tumour cell numbers correlate with platelet count and circulating lymphocyte subsets in men with advanced prostate cancer: Data from the ExPeCT clinical trial … B Hayes, L Brady, G Sheill, AM Baird, E Guinan, B Stanfill, J Dunne, ... Cancers 13 (18), 4690, 2021 | 15 | 2021 |
| Differential CircRNA expression signatures may serve as potential novel biomarkers in prostate cancer J Greene, AM Baird, M Lim, J Flynn, C McNevin, L Brady, O Sheils, ... Frontiers in cell and developmental biology 9, 605686, 2021 | 12 | 2021 |
| A comparison of prostate cancer cell transcriptomes in 2D monoculture vs 3D xenografts identify consistent gene expression alterations associated with tumor microenvironments L Brady, RM Gil da Costa, IM Coleman, CK Matson, MC Risk, ... The Prostate 80 (6), 491-499, 2020 | 10 | 2020 |
| The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial G Sheill, L Brady, E Guinan, B Hayes, O Casey, J Greene, T Vlajnic, ... Trials 18, 1-12, 2017 | 10 | 2017 |
| Co-targeting PIM kinase and PI3K/mTOR in NSCLC G Moore, C Lightner, S Elbai, L Brady, S Nicholson, R Ryan, ... Cancers 13 (9), 2139, 2021 | 8 | 2021 |
| Correlation of integrated ERG/PTEN assessment with biochemical recurrence in prostate cancer L Brady, J Carlsson, AM Baird, O Casey, T Vlajnic, P Murchan, ... Cancer Treatment and Research Communications 29, 100451, 2021 | 7 | 2021 |
| RISING STARS: Heterogeneity and the tumor microenvironment in neuroendocrine prostate cancer L Brady, PS Nelson Journal of Endocrinology 256 (2), 2023 | 6 | 2023 |
| Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance L Brady, LF Newcomb, K Zhu, Y Zheng, H Boyer, ND Sarkar, ... Cancer Medicine 11 (22), 4332-4340, 2022 | 4 | 2022 |
| The effect of a structured exercise intervention on CTCs and platelet cloaking in patients with metastatic prostate cancer. L Brady, B Hayes, G Sheill, AM Baird, EM Guinan, B Stanfill, T Vlajnic, ... Journal of Clinical Oncology 37 (7_suppl), 243-243, 2019 | 2 | 2019 |
| ExPeCT: a randomised trial examining the impact of exercise on quality of life in men with metastatic prostate cancer G Sheill, L Brady, B Hayes, AM Baird, E Guinan, R Vishwakarma, ... Supportive Care in Cancer 31 (5), 292, 2023 | 1 | 2023 |
| A randomized trial of exercise on quality of life in men with metastatic prostate cancer: The ExPeCT Trial. G Sheill, L Brady, EM Guinan, JM Hussey, B Hayes, AM Baird, B Stanfill, ... Journal of Clinical Oncology 37 (31_suppl), 97-97, 2019 | 1 | 2019 |
